EC

Everus Construction Group, Inc.

ECGIndustrialsNASDAQ

Engineering & Construction · Last scanned Oct 24, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$3.75B
+31.5% YoY
Net Income
$201.8M
+40.7% YoY
EBITDA
$308.1M
+40.0% YoY
Free Cash Flow
$184.4M

Scan Results

Daily timeframe
2 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 19▼ MACD Negative CrossoverHistogram -1.1126, negative momentum
Oct 17▼ MACD Negative CrossoverHistogram -1.1126, negative momentum
About Everus Construction Group, Inc.

Headquartered within the industrials sector, Everus Construction Group, Inc. focuses on Engineering & Construction services and products. Everus Construction Group, Inc. provides contracting services in the United States. The $4.85B market capitalization puts ECG squarely in mid-cap range for its industry. It operates through two segments, Electrical & Mechanical and Transmission & Distribution.

Where ECG stands vs its 150-day and 200-day moving averages

As of the October 19, 2026 close, ECG finished 17.83% below its 150-day moving average ($133.45) and 12.34% below its 200-day moving average ($125.09). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is ECG overbought or oversold?

At the October 19, 2026 close, ECG's RSI(14) was 41.3, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$4.85B
P/E (TTM)19.10
Fwd P/E15.09
EPS$4.97
52W Change+1.1%
Dividend Yield0.00%
ROE39.5%
Analysis

On the balance sheet, ECG has $157.7M in cash with $364.2M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $184.4M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 39.5%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 11.7% further supports the picture of efficient asset utilization. Revenue has grown from $2.70B (2022) to $3.75B (2025), reflecting a 39% increase over the period.

As with any equity investment, ECG carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing ECG.

Links
More Industrials stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms